The cardiac amyloidosis diagnostic algorithm should always begin with a monoclonal protein screen to assess for the presence of a plasma cell disorder and, therefore, supportive evidence for AL-CM ...

An artificial intelligence-guided algorithm to identify cardiac amyloidosis received a breakthrough device designation from the FDA. Earlier identification could improve care of patients with ...

Another name for this condition is cardiac amyloidosis. This article will discuss amyloid heart disease, including its symptoms, causes, diagnosis, risk factors, and treatment options.

The duo announced their partnership late last year, pledging to spend the next several years working together to bring the cardiac amyloidosis-spotting tech into clinics in the U.S., Europe and Japan.

Anumana Inc. has garnered a U.S. FDA breakthrough device designation for its artificial intelligence (AI)-powered electrocardiogram-based algorithm for early identification of cardiac amyloidosis. The ...

[1] Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence. The Lancet Digital Health (2024).

Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the University of Oxford, UK, has entered into an agreement with Pfizer to support the validation and FDA ...

The plan is to develop a new AI-ECG algorithm to help identify patients who may be at risk of cardiac amyloidosis. As per the partnership, Anumana will conduct a clinical validation trial and pursue ...

Common conditions that can lead to heart failure include coronary artery disease, high blood pressure, previous heart attack, amyloidosis, sarcoidosis, and some nutritional deficiencies.

“Cardiac amyloidosis is a challenging rare condition with an incidence of about 1 in 1,000 people with about 500 to 600 new cases in the [United Kingdom] every year (according to the UCL ...

In parallel, comprehensive reviews of transthyretin amyloid cardiomyopathy have highlighted the crucial role of early detection and the application of disease-modifying therapies, such as TTR ...